HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of a bladder cancer cluster in a population of criminal investigators with the Bureau of Alcohol, Tobacco, Firearms and Explosives-part 1: the cancer incidence.

Abstract
This study investigated a bladder cancer cluster in a cohort of employees, predominately criminal investigators, participating in a medical surveillance program with the United States Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) between 1995 and 2007. Standardized incidence ratios (SIRs) were used to compare cancer incidences in the ATF population and the US reference population. Seven cases of bladder cancer (five cases verified by pathology report at time of analysis) were identified among a total employee population of 3,768 individuals. All cases were white males and criminal investigators. Six of seven cases were in the 30 to 49 age range at the time of diagnosis. The SIRs for white male criminal investigators undergoing examinations were 7.63 (95% confidence interval = 3.70-15.75) for reported cases and 5.45 (2.33-12.76) for verified cases. White male criminal investigators in the ATF population are at statistically significant increased risk for bladder cancer.
AuthorsSusan R Davis, Xuguang Tao, Edward J Bernacki, Amy S Alfriend
JournalJournal of environmental and public health (J Environ Public Health) Vol. 2012 Pg. 101850 ( 2012) ISSN: 1687-9813 [Electronic] United States
PMID23304175 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Explosive Agents
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Bombs
  • Carcinoma, Transitional Cell (epidemiology)
  • Cluster Analysis
  • Explosive Agents (adverse effects)
  • Female
  • Fires
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Occupational Exposure
  • Police
  • Risk Factors
  • United States (epidemiology)
  • Urinary Bladder Neoplasms (epidemiology)
  • Workforce
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: